Mayo Clinic Sued Over AI Research Safety and Oversight Practices

Lawsuit alleges compromised research integrity

Mayo Clinic is facing a federal lawsuit from its former director of research operations, who claims the health system systematically undermined safety protocols to accelerate its artificial intelligence research program. Traci Tamiko Eto alleges she was terminated in 2023 after repeatedly raising concerns about how Mayo handled institutional review board (IRB) oversight for AI-related medical studies.

The complaint, filed Monday in U.S. District Court in Minnesota, accuses Mayo leadership of manipulating the independent review process designed to ensure research meets ethical and safety standards. According to the lawsuit, supervisors allegedly pressured IRBs to approve questionable studies, directed proposals to less rigorous review boards, or bypassed the oversight process entirely by approving research internally.

Why it matters

Institutional review boards serve as the primary safeguard ensuring medical research protects patient safety and privacy while maintaining scientific integrity. If a major health system is circumventing these controls to maintain competitive advantage in AI development, it raises questions about the reliability of AI tools entering clinical practice and the security of patient data used to train them. The case arrives as healthcare organizations race to deploy AI across diagnostic and clinical workflows, often with limited regulatory oversight.

Specific allegations about AI tools and data privacy

Eto's lawsuit details several concerning incidents during her tenure. She claims Mayo researchers attempted to suppress findings showing the organization's MAYA digital assistant produced errors in 67% of cases. In another instance, she objected to using an unvetted AI-enabled cardiac device in a surgery performed overseas, but her supervisor allegedly overrode her concerns and approved the procedure.

The former director also questioned whether Mayo had adequately protected patient privacy in its Mayo Clinic Platform initiative, which analyzes large volumes of de-identified health data to develop diagnostic tools. Eto was hired in 2023 specifically to oversee ethics and integrity for AI research, according to her attorney Artur Davis, who described her as a "rising star" before the disputes began.

Retaliation claims and patent dispute

After raising these concerns, Eto alleges supervisors stripped her of authority and responsibilities. She took medical leave for work-related depression, and upon returning was given weeks to find another position at Mayo or face termination. The lawsuit also claims Mayo minimized Eto's contributions in a patent application for an AI tool she helped create, potentially limiting her financial interest in its commercial use.

Mayo Clinic has positioned itself as a leader in healthcare AI development, recently hosting a conference showcasing research on AI applications ranging from predicting cognitive decline to assessing tumor severity. The organization is Minnesota's largest employer.

This case represents Mayo's second recent legal confrontation with a researcher. Earlier this year, a jury dismissed claims by Dr. Michael Joyner that Mayo had improperly restricted his public comments about COVID-19 pandemic policies, though Joyner has requested a new trial.

These details were first reported by the Star Tribune.